These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 16547033)

  • 1. Cross-linked peptidoglycan mediates lysostaphin binding to the cell wall envelope of Staphylococcus aureus.
    Gründling A; Schneewind O
    J Bacteriol; 2006 Apr; 188(7):2463-72. PubMed ID: 16547033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staphylococcus aureus mutants with increased lysostaphin resistance.
    Gründling A; Missiakas DM; Schneewind O
    J Bacteriol; 2006 Sep; 188(17):6286-97. PubMed ID: 16923896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lysostaphin endopeptidase resistance gene (epr) specifies modification of peptidoglycan cross bridges in Staphylococcus simulans and Staphylococcus aureus.
    DeHart HP; Heath HE; Heath LS; LeBlanc PA; Sloan GL
    Appl Environ Microbiol; 1995 Apr; 61(4):1475-9. PubMed ID: 7747966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. epr, which encodes glycylglycine endopeptidase resistance, is homologous to femAB and affects serine content of peptidoglycan cross bridges in Staphylococcus capitis and Staphylococcus aureus.
    Sugai M; Fujiwara T; Ohta K; Komatsuzawa H; Ohara M; Suginaka H
    J Bacteriol; 1997 Jul; 179(13):4311-8. PubMed ID: 9209049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Target cell specificity of a bacteriocin molecule: a C-terminal signal directs lysostaphin to the cell wall of Staphylococcus aureus.
    Baba T; Schneewind O
    EMBO J; 1996 Sep; 15(18):4789-97. PubMed ID: 8890152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural bases of peptidoglycan recognition by lysostaphin SH3b domain.
    Mitkowski P; Jagielska E; Nowak E; Bujnicki JM; Stefaniak F; Niedziałek D; Bochtler M; Sabała I
    Sci Rep; 2019 Apr; 9(1):5965. PubMed ID: 30979923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell wall monoglycine cross-bridges and methicillin hypersusceptibility in a femAB null mutant of methicillin-resistant Staphylococcus aureus.
    Strandén AM; Ehlert K; Labischinski H; Berger-Bächi B
    J Bacteriol; 1997 Jan; 179(1):9-16. PubMed ID: 8981974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of the Monofunctional Peptidoglycan Glycosyltransferase SgtB Allows
    Karinou E; Schuster CF; Pazos M; Vollmer W; Gründling A
    J Bacteriol; 2019 Jan; 201(1):. PubMed ID: 30322854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substrate Preferences Establish the Order of Cell Wall Assembly in Staphylococcus aureus.
    Schaefer K; Owens TW; Kahne D; Walker S
    J Am Chem Soc; 2018 Feb; 140(7):2442-2445. PubMed ID: 29402087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-site recognition of Staphylococcus aureus peptidoglycan by lysostaphin SH3b.
    Gonzalez-Delgado LS; Walters-Morgan H; Salamaga B; Robertson AJ; Hounslow AM; Jagielska E; Sabała I; Williamson MP; Lovering AL; Mesnage S
    Nat Chem Biol; 2020 Jan; 16(1):24-30. PubMed ID: 31686030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of murein hydrolase targeting to cross-wall of Staphylococcus aureus peptidoglycan.
    Frankel MB; Schneewind O
    J Biol Chem; 2012 Mar; 287(13):10460-10471. PubMed ID: 22303016
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Raulinaitis V; Tossavainen H; Aitio O; Seppala R; Permi P
    Biomol NMR Assign; 2017 Apr; 11(1):69-73. PubMed ID: 27943001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of staphylococcal wall teichoic acid in targeting the major autolysin Atl.
    Schlag M; Biswas R; Krismer B; Kohler T; Zoll S; Yu W; Schwarz H; Peschel A; Götz F
    Mol Microbiol; 2010 Feb; 75(4):864-73. PubMed ID: 20105277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of Polycations on Antibacterial Activity of Lysostaphin].
    Kulikov SN; Khairullin RZ; Varlamov VP
    Prikl Biokhim Mikrobiol; 2015; 51(6):610-5. PubMed ID: 26859963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of the antibacterial peptidase lysostaphin from Staphylococcus simulans: Adverse influence of Zn
    Chandra Ojha S; Imtong C; Meetum K; Sakdee S; Katzenmeier G; Angsuthanasombat C
    Protein Expr Purif; 2018 Nov; 151():106-112. PubMed ID: 29944958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell wall composition and decreased autolytic activity and lysostaphin susceptibility of glycopeptide-intermediate Staphylococcus aureus.
    Koehl JL; Muthaiyan A; Jayaswal RK; Ehlert K; Labischinski H; Wilkinson BJ
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3749-57. PubMed ID: 15388430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Teichoic acids are temporal and spatial regulators of peptidoglycan cross-linking in Staphylococcus aureus.
    Atilano ML; Pereira PM; Yates J; Reed P; Veiga H; Pinho MG; Filipe SR
    Proc Natl Acad Sci U S A; 2010 Nov; 107(44):18991-6. PubMed ID: 20944066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staphylococcus aureus mutants lacking the LytR-CpsA-Psr family of enzymes release cell wall teichoic acids into the extracellular medium.
    Chan YG; Frankel MB; Dengler V; Schneewind O; Missiakas D
    J Bacteriol; 2013 Oct; 195(20):4650-9. PubMed ID: 23935043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FmhA and FmhC of
    Willing S; Dyer E; Schneewind O; Missiakas D
    J Biol Chem; 2020 Sep; 295(39):13664-13676. PubMed ID: 32759309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lif, the lysostaphin immunity factor, complements FemB in staphylococcal peptidoglycan interpeptide bridge formation.
    Tschierske M; Ehlert K; Strandén AM; Berger-Bächi B
    FEMS Microbiol Lett; 1997 Aug; 153(2):261-4. PubMed ID: 9271851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.